Adaptable antigen matrix platforms for peptide vaccination strategies and T cell-mediated anti-tumor immunity
Open Access
- 1 December 2020
- journal article
- research article
- Published by Elsevier in Biomaterials
- Vol. 262, 120342
Abstract
No abstract availableKeywords
Funding Information
- European Research Council
This publication has 64 references indexed in Scilit:
- Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletionNature Medicine, 2013
- Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88Proceedings of the National Academy of Sciences, 2011
- Designing Vaccines Based on Biology of Human Dendritic Cell SubsetsImmunity, 2010
- Vaccine Adjuvants: Putting Innate Immunity to WorkImmunity, 2010
- Reverse Vaccinology: Developing Vaccines in the Era of GenomicsImmunity, 2010
- Microbial Stimulation Fully Differentiates Monocytes to DC-SIGN/CD209+ Dendritic Cells for Immune T Cell AreasCell, 2010
- Pattern Recognition Receptors and InflammationCell, 2010
- Toll-like Receptors Activate Innate and Adaptive Immunity by using Dendritic Cell-Intrinsic and -Extrinsic MechanismsImmunity, 2008
- Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fatesJournal of Experimental Medicine, 2008
- Inflammation Directs Memory Precursor and Short-Lived Effector CD8+ T Cell Fates via the Graded Expression of T-bet Transcription FactorImmunity, 2007